MD Anderson Cancer Center - University of Texas is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
MD Anderson Cancer Center - University of Texas has participated in 6 clinical trials with 4 currently active.
Therapeutic areas: Relapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma, HER2 Mutation-Related Tumors, HER2.
Sponsors: Allogene Therapeutics, Iambic Therapeutics, Inc, Jonsson Comprehensive Cancer Center.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
MD Anderson Cancer Center - University of Texas has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MD Anderson Cancer Center - University of Texas has 6 clinical trials on record, with 4 currently active. Their work covers Relapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma, HER2 Mutation-Related Tumors, HER2.
Yes — MD Anderson Cancer Center - University of Texas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.